Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
Department of Ophthalmology, School of Medcine, Kangwon National University, Chuncheon, Kangwon, Korea
I read with great interest the recent study by Michalska-MaĹ‚ecka et al1 published in the journal Clinical Interventions in Aging. The authors investigated the impact of intravitreal dexamethasone implant on macular morphology and functions in eyes with macular edema (ME) secondary to branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). I congratulate the authors for their enlightening study and would like to make some contributions to the study.
Read the original article by Michalska-MaĹ‚ecka and colleagues.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]